Ares Commercial Real Estate (ACRE) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
10 Feb, 2026Executive summary
2025 was a transitional year with early macroeconomic uncertainty, but conditions improved as the Fed eased policy, stabilizing values and boosting transaction volumes.
Reported a GAAP net loss of $0.9 million ($0.02 per share) for 2025 and a Q4 net loss of $3.9 million ($0.07 per share); distributable earnings loss of $6.7 million ($0.12 per share) for the year and $8.5 million ($0.15 per share) in Q4.
Focused on reducing risk-rated 4 and 5 loans, decreasing office and OREO assets, and reshaping the portfolio through new investments.
Achieved balance sheet flexibility with moderate leverage and over $100 million in liquidity.
Declared a $0.15 per share dividend for Q1 2026, implying a 12% annualized yield.
Financial highlights
Loan portfolio principal balance grew to $1.6 billion, up 24% from Q3 2025; total portfolio was $1.7 billion at year-end.
Interest income for Q4 2025 was $23.7 million; full year 2025 was $97.6 million.
Net interest margin for Q4 2025 was $7.7 million; full year 2025 was $32.4 million.
$572 million in loan repayments collected during 2025.
Book value per share was $9.26, including the CECL reserve.
Outlook and guidance
Focus remains on resolving the five remaining risk-rated 4 and 5 loans, especially the large Chicago office and Brooklyn condo loans.
Available capital of $110 million supports continued asset resolutions and new investments.
Closed $150 million in new loan commitments after year-end 2025.
Over 60% of FY 2025 commitments were co-invested with other Ares managed funds.
Earnings trajectory may be uneven due to asset resolutions, but confidence in meeting dividend level is strong.
Latest events from Ares Commercial Real Estate
- Q2 2024 net loss of $6.1M, high CECL reserves, and a $0.25 dividend declared.ACRE
Q2 20242 Feb 2026 - Q3 net loss of $5.9M, risk loan reduction, and $0.25 dividend declared.ACRE
Q3 202415 Jan 2026 - Net loss in 2024, but leverage, liquidity, and risk exposure improved.ACRE
Q4 20245 Jan 2026 - Annual meeting to vote on directors, auditor, executive pay, and governance policies.ACRE
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and say-on-pay at the 2025 meeting.ACRE
Proxy Filing1 Dec 2025 - Net loss of $11M, $33M loan loss, but liquidity and new loan activity improved.ACRE
Q2 202523 Nov 2025 - Q1 2025 net income was $9.3M, liquidity improved, and a $0.15 dividend was declared.ACRE
Q1 202521 Nov 2025 - Q3 2025 delivered $5M net income, strong liquidity, and major new loan commitments.ACRE
Q3 202514 Nov 2025